Pfizer Global Product Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer global product development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Global Product Development Today - Breaking & Trending Today

FDA Approves Braftovi and Mektovi for Some Patients with Metastatic NSCLC

Braftovi (encorafenib) with Mektovi (binimetinib) has been approved for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, the agency announced on Wednesday evening. ....

Foundationone Cdx , Chris Boshoff , Pfizer Global Product Development , Drug Administration , Foundationone Liquid , Supplemental New Drug Application , Clinical Oncology , Lung Cancer ,

Pfizer Inc. Leaders, Founders, and Executives: Who Are They?

Pfizer is a research-based pharmaceutical and biomedical giant. Get to know the Pfizer Inc. leaders, founders, and executives here ....

New York , United States , William Pao , Josephj Echevarria , Angela Hwang , Shantanu Narayen , Aamar Malik , Danr Littman , Mike Mcdermott , Ronalde Blaylock , Sally Susman , Susan Desmond Hellmann , Jamesc Smith , Olidia Fonseca , Mikael Dolsten , Doug Lankler , Helenh Hobbs , Charles Erhart , Aamir Malik , Suzanne Nora Johnson , Albert Bourla , Dave Denton , Payal Sahni Becher , Scott Gottlieb , James Quincey , Susan Hockfield ,

Cardiff Oncology Advances Colorectal Cancer Treatment - San Diego Business Journal

Cardiff Oncology Advances Colorectal Cancer Treatment - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Mark Erlander , Jamie Levine , Adam Schayowitz , Cardiff Oncology Inc , Pfizer Global Product Development , Cardiff Oncology , Pfizer Ignite ,

Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug. ....

Richa Kumari , James Levine , Mark Erlander , Kiki Patel , Gilmartin Group , Exchange Commission , Pfizer Global Product Development , Dana Farber Cancer Institute , Prnewswire Cardiff Oncology Inc , Cardiff Oncology Inc , Medicine Team Group Lead For Breast Cancer , Taft Communications , Cardiff Oncology , Chief Executive Officer , Pfizer Ignite , Vice President , Medicine Team Group Lead , Breast Cancer , Colorectal Cancer , Scientific Advisory Board , Private Securities Litigation Reform Act , Oncology Contact , Financial Officer , Months Ended June , Health Care Amp Hospitals , Medical Pharmaceuticals ,

Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship

- Advance to first-line RAS-mutated mCRC follows the strong signal from new clinical and preclinical data, and agreement with FDA -
- First-line mCRC represents substantial increase in patient. ....

Kiki Patel , Mark Erlander , James Levine , Adam Schayowitz , Fairooz Kabbinavar , Richa Kumari , Medicine Team Group Lead For Breast Cancer , Gilmartin Group , Taft Communications , Prnewswire Cardiff Oncology Inc , Cardiff Oncology Inc , Exchange Commission , Pfizer Inc , Pfizer Global Product Development , Pfizer Ignite , Cardiff Oncology , Chief Executive Officer , Vice President , Medicine Team Group Lead , Breast Cancer , Colorectal Cancer , Scientific Advisory Board , Chief Medical Officer , Private Securities Litigation Reform Act , Oncology Contact ,